Your prediction
Coty Inc Stock
The price for the Coty Inc stock decreased slightly today. Compared to yesterday there is a change of -€0.020 (-0.850%).
Our community identified positive and negative aspects for Coty Inc stock for the coming years. 0 users see the criterium "EBIT growth" as a plus for the Coty Inc stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Coty Inc in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Coty Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Coty Inc | -0.850% | 1.739% | 23.158% | -46.379% | -9.722% | -78.469% | -68.258% |
| Inter Parfums Inc. | -2.770% | 3.735% | 15.369% | 2.870% | 54.306% | -18.309% | - |
| Spectrum Brands Holdings, Inc | - | -1.299% | 1.333% | 60.338% | 50.495% | 8.571% | 3.401% |
| Nu Skin Enterprises A | -2.000% | 2.919% | -0.822% | -38.880% | -44.098% | -82.896% | -89.795% |
Comments
News
Coty Q3 Earnings Call Highlights
Coty (NYSE:COTY) executives said the beauty company is working to narrow the gap between retail sell-out and sell-in, sharpen its
Stock Market Today, Feb. 18: Kenvue Rises After Earnings Beat Expectations
Kenvue (NYSE:KVUE), maker of consumer health products including Tylenol, Neutrogena, and Listerine, closed Wednesday at $18.88, up 2.55%. The stock moved higher after Q4 results beat expectations
